INHIBITEX, INC. (INHX) [Rocket]

In millions, except per share items	Sep-30-11	Jun-30-11	Mar-31-11	Dec-31-10	Sep-30-10	Jun-30-10	Mar-31-10	Dec-31-09
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Net income	-25.0	-25.0	-25.3	-22.7	-20.3	-19.5	-18.2	-17.6
Depreciation and amortization	0.6	0.6	0.6	0.6	0.6	0.8	0.8	0.8
Stock-based compensation	1.5	1.4	1.2	0.9	0.5	0.5	0.5	0.5
Change in working capital [+]	-0.8	-1.4	2.4	1.3	0.5	1.4	0.7	0.3
Accounts receivable	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0
Other current assets	-0.8	-0.3			0.2	0.2
Accounts payable	-0.3	-1.2			-0.1	0.6
Accrued expenses	-0.4	-0.2			0.6	-0.1
Deferred revenues	-0.1	-0.4			-0.1	0.2
Other		0.7	1.8	0.7		0.5	0.7	0.5
Other operating activities	1.5	1.3	-0.3	1.5	0.5	0.5	0.3	-0.2
Cash from operations	-22.3	-23.2	-21.3	-18.4	-18.2	-16.4	-15.9	-16.1

Capital expenditures	-0.1	-0.1	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1
Purchases of property and equipment	-0.1	-0.1		-0.1	-0.2		-0.1	-0.1
Sales of short-term investments, net [+]	-9.4	-5.5		28.8	26.4	19.2	13.0	7.6
Purchases of short-term investments	-37.3	-29.8		0.0	-2.4	3.7	13.0	7.6
Sales of short-term investments	27.9	24.3			28.8	15.5
Other cash from investing		-13.6	-8.9	-13.6		-23.9	-18.1	-12.8
Cash from investing	-23.1	-19.2	22.2	15.1	-2.8	-4.9	-5.2	-5.2

Issuance of common stock, net		51.0	0.2	0.2		0.0	0.0	0.0
Option exercises	2.0	1.8			0.7	0.5
Other cash from financing	3.4	3.0	1.1	1.1	22.5	22.0	21.2	21.1
Cash from financing	52.4	52.2	0.6	0.6	21.9	21.5	21.2	21.2

Free cash flow	-22.4	-23.3	-21.4	-18.5	-18.3	-16.5	-16.1	-16.2
Per share (diluted)	($0.32)	($0.36)	($0.34)	($0.30)	($0.32)	($0.31)	($0.33)	($0.37)

Cash paid for interest	0.0	0.0			0.0	0.0